Transcriptional regulation of the Igκ gene by promoter-proximal pausing of RNA polymerase II

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4375-4382

  Raschke, Eva E ^a   Albert, Thomas ^a,b   Eick, Dirk ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; RNA POLYMERASE II;

ANIMAL CELL; ARTICLE; GENE REARRANGEMENT; IMMUNOGLOBULIN GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; RAT; RNA TRANSLATION; SOMATIC MUTATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0032844742     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Paige, C. J., P. W. Kincade, and P. Ralph. 1978. Murine B cell leukemia line with inducible surface immunoglobulin expression. J. Immunol. 121:641.
2. Wall, R., and M. Kuehl. 1983. Biosynthesis and regulation of immunoglobulins. Annu. Rev. Immunol. 1:393.
3. Maki, R., J. Kearney, C. Paige, and S. Tonegawa. 1980. Immunoglobulin gene rearrangement in immature B cells. Science 209:1366.
4. Sen, R., and D. Baltimore. 1986. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921.
5. Lenardo, M., J. W. Pierce, and D. Baltimore. 1987. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236: 1573.
6. Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 33:741.
7. Picard, D., and W. Schaffner. 1984. A lymphocyte-specific enhancer in the mouse immunoglobulin κ gene. Nature 307:80.
8. Staudt, L. M., and M. J. Lenardo. 1991. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9:373.
9. Cockerill, P. N., and W. T. Garrard. 1986. Chromosomal loop anchorage of the κ immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44:273.
10. Meyer, K. B., and M. S. Neuberger. 1989. The immunoglobulin κ locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 8:1959.
11. Blasquez, V. C., M. Xu, S. C. Moses, and W. T. Garrard. 1989. Immunoglobulin κ gene expression after stable integration. I. Role of the intronic MAR and enhancer in plasmacytoma cells. J. Biol. Chem. 264:21183.
12. Blasquez, V. C., M. A. Hale, K. W. Trevorrow, and W. T. Garrard. 1992. Immunoglobulin κ gene enhancers synergistically activate gene expression but independently determine chromatin structure. J. Biol. Chem. 267:23888.
13. Pongubala, J. M., and M. L. Atchison. 1991. Functional characterization of the developmentally controlled immunoglobulin κ 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol. Cell. Biol. 11:1040.
14. Fulton, R., and B. Van-Ness. 1993. κ immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res. 21:4941.
15. Henderson, A. J., and K. L. Calame. 1995. Lessons in transcriptional regulation learned from studies on immunoglobulin genes. Crit. Rev. Eukaryotic Gene Expression 5:255.
16. Jenuwein, T., W. C. Forrester, L. A. Fernandez-Herrero, G. Laible, M. Dull, and R. Grosschedl. 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385:269.
17. Lichtenstein, M., G. Keini, H. Cedar, and Y. Bergman. 1994. B cell-specific demethylation: a novel role for the intronic κ chain enhancer sequence. Cell 76:913.
18. Takeda, S., Y. R. Zou, H. Bluethmann, D. Kitamura, U. Muller, and K. Rajewsky. 1993. Deletion of the immunoglobulin κ chain intron enhancer abolishes κ chain gene rearrangement in cis but not λ chain gene rearrangement in trans. EMBO J. 12:2329.
19. Hiramatsu, R., K. Akagi, M. Matsuoka, K. Sakumi, H. Nakamura, L. Kingsbury, C. David, R. R. Hardy, K. Yamamura, and H. Sakano. 1995. The 3′ enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin Vκ-Jκ joining. Cell 83:1113.
20. Wagner, S. D., and M. S. Neuberger. 1996. Somatic hypermutation of immunoglobulin genes. Annu. Rev. Immunol. 14:441.
21. Krumm, A., T. Meulia, M. Brunvand, and M. Groudine. 1992. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev. 6:2201.
22. Strobl, L. J., and D. Eick. 1992. Holdback of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J. 11:3307.
23. Lis, J., and C. Wu. 1993. Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell 74:1.
24. Plet, A., D. Eick, and J. M. Blanchard. 1995. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns. Oncogene 10:319.
25. Yankulov, K., J. Blau, T. Purton, S. Roberts, and D. L. Bentley. 1994. Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 77:749.
26. Croce, C. M. 1993. Molecular biology of lymphomas. Semin. Oncol. 20:31.
27. Strobl, L. J., F. Kohlhuber, J. Mautner, A. Polack, and D. Eick. 1993. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift. Oncogene 8:1437.
28. Hortnagel, K., J. Mautner, L. J. Strobl, D. A. Wolf, B. Christoph, C. Geltinger, and A. Polack. 1995. The role of immunoglobulin κ elements in c-myc activation. Oncogene 10:1393.
29. Parslow, T. G., D. L. Blair, W. J. Murphy, and D. K. Granner. 1984. Structure of the 5′ ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81:2650.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
31. Garrity, P. A., and B. J. Wold. 1992. Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting. Proc. Natl. Acad. Sci. USA 89:1021.
32. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780.
33. Allenburger, W., M. Steinmetz, and H. G. Zachau. 1980. Functional and nonfunctional joining in immunoglobulin light chain genes of a mouse myeloma. Nature 287:603.
34. Lee, G., L. R. Ellingsworth, S. Gillis, R. Wall, and P. W. Kincade. 1987. β transforming growth factors are potential regulators of B lymphopoiesis. J. Exp. Med. 166:1290.
35. Wang, W., M. Carey, and J. D. Gralla. 1992. Polymerase II promoter activation: closed complex formation and ATP-driven start site opening. Science 255:450.
36. Mecsas, J., and B. Sugden. 1987. Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Annu. Rev. Cell Biol. 3:87.
37. Lee, H., K. W. Kraus, M. F. Wolfner, and J. T. Lis. 1992. DNA sequence requirements for generating paused polymerase at the start of hsp70. Genes Dev. 6:284.
38. Epstein, M. A., B. G. Achong, Y. M. Barr, B. Zajac, G. Henle, and W. Henle. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:547.
39. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812.
40. Marienfeld, R., M. Neumann, S. Chuvpilo, C. Escher, B. Kneitz, A. Avots, A. Schimpl, and E. Serfling. 1997. Cyclosporin A interferes with the inducible degradation of NF-κB inhibitors, but not with the processing of p105/NF-κB1 in T cells. Eur. J. Immunol. 27:1601.
41. Holschermann, H., F. Durfeld, U. Maus, A. Bierhaus, K. Heidinger, J. Lohmeyer, P. P. Nawroth, H. Tillmanns, and W. Haberbosch. 1996. Cyclosporine A inhibits tissue factor expression in monocytes/macrophages. Blood 88:3837.
42. Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate I κB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861.
43. Meyer, S., N. G. Kohler, and A. Joly. 1997. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation. FEBS Lett. 413: 354.
44. Bentley, D. L. 1995. Regulation of transcriptional elongation by RNA polymerase II. Curr. Opin. Genet. Dev. 5:210.
45. Giardina, C., M. Perez Riba, and J. T. Lis. 1992. Promoter melting and TFIID complexes on Drosophila genes in vivo. Genes Dev. 6:2190.
46. Wolf, D. A., L. J. Strobl, A. Pullner, and D. Eick. 1995. Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity. Nucleic Acids Res. 23:3373.
47. Sweet, M. J., and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukocyte Biol. 60:8.
48. Nelms, K., R. Hromas, and B. Van Ness. 1990. Identification of a second inducible DNA-protein interaction in the κ immunoglobulin enhancer. Nucleic Acids Res. 18:1037.
49. Nelms, K., and B. Van Ness. 1990. Identification of an octamer-binding site in the human κ light-chain enhancer. Mol. Cell. Biol. 10:3843.
50. Schanke, J. T., A. Marcuzzi, R. P. Podzorski, and B. Van-Ness. 1994. An AP1 binding site upstream of the κ immunoglobulin intron enhancer binds inducible factors and contributes to expression. Nucleic Acids Res. 22:5425.
51. O'Brien, T., S. Hardin, A. Greenleaf, and J. T. Lis. 1994. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 370:75.
52. Greenblatt, J. 1997. RNA polymerase II holoenzyme and transcriptional regulation. Curr. Opin. Cell Biol. 9:310.
53. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:2622.
54. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451.
55. Albert, T., J. Mautner, J. O. Funk, K. Hortnagel, A. Pullner, and D. Eick. 1997. Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II. Mol. Cell. Biol. 17:4363.
56. Madisen, L., A. Krumm, T. R. Hebbes, and M. Groudine. 1998. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes. Mol. Cell. Biol. 18:6281.
57. Gerritsen, M. E., A. J. Williams, A. S. Neish, S. Moore, Y. Shi, and T. Collins. 1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94:2927.
58. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523.
59. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661.
60. Sandaltzopoulos, R., and P. B. Becker. 1998. Heat shock factor increases the reinitiation rale from potentiated chromatin templates. Mol. Cell. Biol. 18:361.
61. O'Brien, D. P., E. M. Oltz, and B. G. Van Ness. 1997. Coordinate transcription and V(D)J recombination of the κ immunoglobulin light-chain locus: NF-κB-dependent and -independent pathways of activation. Mol. Cell. Biol. 17:3477.
62. Briskin, M., M. D. Kuwabara, D. S. Sigman, and R. Wall. 1988. Induction of κ transcription by interferon-γ without activation of NF-κB. Science 242:1036.
63. Rogerson, B. J. 1994. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes. Mol. Immunol. 31:83.
64. Rada, C., A. Gonzalez Fernandez, J. M. Jarvis, and C. Milstein. 1994. The 5′ boundary of somatic hypermutation in a Vκ gene is in the leader intron. Eur. J. Immunol. 24:1453.
65. Neuberger, M. S., and C. Milstein. 1995. Somatic hypermutation. Curr. Opin. Immunol. 7:248.
66. Peters, A., and U. Storb. 1996. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4:57.
67. Mortillaro, M. J., B. J. Blencowe, X. Wei, H. Nakayasu, L. Du, S. L. Warren, P. A. Sharp, and R. Berezney. 1996. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. USA 93:8253.
68. McCracken, S., N. Fong, K. Yankulov, S. Ballantyne, G. Pan, J. Greenblatt, S. D. Patterson, M. Wickens, and D. L. Bentley. 1997. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357.
69. McCracken, S., N. Fong, E. Rosonina, K. Yankulov, G. Brothers, D. Siderovski, A. Hessel, S. Foster, S. Shuman, and D. L. Bentley. 1997. 5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:3306.
70. Goyenechea, B., N. Klix, J. Yelamos, G. T. Williams, A. Riddell, M. S. Neuberger, and C. Milstein. 1997. Cells strongly expressing Ig(κ) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J. 16:3987.